BCK Capital Management’s Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant FCAX.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-27,193
Closed -$269K 163
2021
Q4
$269K Buy
27,193
+418
+2% +$4.16K 0.18% 107
2021
Q3
$262K Hold
26,775
0.16% 127
2021
Q2
$268K Hold
26,775
0.13% 122
2021
Q1
$268K Buy
+26,775
New +$279K 0.15% 119

Other funds holding FCAX.U

BCK Capital Management's FCAX.U Position: Q1 2022 in Review

BCK Capital Management sold out of Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant (FCAX.U) in Q1 2022, closing a stake of 27,193 shares — an estimated $269K sold.

BCK Capital Management first reported a position in FCAX.U in Q1 2021 and held it in 4 quarters. The position peaked at $269K in Q4 2021. 35 funds tracked by Wall St. Rank hold FCAX.U as of Q1 2022.

  • BCK Capital Management reported no remaining Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant position as of Q1 2022 after selling out during the quarter.
  • BCK Capital Management sold 27,193 Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant shares in Q1 2022, an estimated $269K.
  • BCK Capital Management first reported a position in Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant in Q1 2021 and held it in 4 quarters.
  • BCK Capital Management's Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant position peaked at $269K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Fortress Capital Acquisition Corp. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant as of Q1 2022.

Based on BCK Capital Management's 13F filing for Q1 2022, filed 5 May 2022.